VC

Corporate venture capital (CVC) for startups: how it works

Corporate venture capital is startup investing done by an operating company, usually through a dedicated arm such as Intel Capital or Salesforce Ventures. The investor wants a return like any fund, and it also wants something for the parent: early access to technology, a window into a market, or a future partner. That second goal is what makes a corporate check different from a venture fund’s.

For a founder the useful question is what the parent expects to get. The answer shows up in the clauses written into the deal, so this guide moves from how CVC arms are built, to why corporates invest, to the gains and risks, and ends with a checklist for the terms.

What a corporate venture capital arm is

A CVC arm is a team inside, or funded by, a large company that buys minority stakes in other companies. Most take preferred stock in priced rounds, the same security a traditional fund buys, so the documents look familiar. The term sheet explained guide covers that baseline.

The structures differ in ways that matter to you. Some arms are a business unit that invests the parent’s balance sheet. Others are separate funds with the parent as the only outside investor. GV says Alphabet is its sole limited partner, and Salesforce Ventures says Salesforce is its only source of capital. In both cases the money comes from one corporation, not from a pool of pension funds and endowments, and the arm answers to one parent’s strategy and budget, where a traditional fund answers to many investors for a fixed term.

Independence also varies. GV’s own page says it can invest in direct competitors of Google. M12, Microsoft’s fund, goes the other way: its head, Michelle Gonzalez, says on the M12 site that its investment strategy is tightly aligned to Microsoft. Neither approach is better. They tell you how much of a commercial relationship to expect.

Strategic and financial goals

Practitioners split corporate investors into strategic CVCs, which put the parent’s business first, and financial CVCs, which behave more like a standard venture firm and treat strategic benefit as a bonus. Real programs sit on a spectrum between the two. M12 leans strategic by its own description. GV describes a single limited partner paired with the autonomy of a traditional VC, and says it can back direct competitors of its parent. For a founder, the label matters less than three practical points: who decides, what the parent hopes to gain, and what the CVC will do if those goals conflict with yours. A strategic CVC may value a pilot with the parent company’s business unit above a quick exit, while a CVC run for financial returns cares more about price and the next round.

Traditional venture fund Corporate venture arm
Source of capital Many outside investors (limited partners) One parent company, often the only source (GV, Salesforce Ventures)
Main goal Financial return to its investors Financial returns plus a strategic benefit for the parent
What it adds beyond cash Network, hiring help, follow-on rounds Customers, technology, distribution and a partner brand
Typical founder worry Price and control Conflicts, information sharing and signaling

The table is a simplification based on how the programs describe themselves, not a rule. Some funds also provide customer introductions, and some CVC arms behave exactly like a financial investor.

Why corporations invest in startups

Corporate investors give a handful of reasons, and one deal can combine several:

  • Technology and talent. A startup can test an idea faster than a research lab, and a minority stake gives the corporation a look at it.
  • Market intelligence. A board seat or observer role shows how a new product category is developing.
  • Ecosystem growth. A company that sells a platform benefits when startups build on it. Salesforce Ventures says its link to Salesforce gives portfolio companies access to the Salesforce ecosystem, and Intel Capital’s page describes its focus as the future of compute.
  • Possible acquisition. An investment can precede a purchase, although it does not usually lead to one. Salesforce Ventures says Salesforce has acquired fewer than 5% of its portfolio companies, a figure from its own page as of July 2026.
  • Financial returns. A CVC is rarely a charity. Salesforce Ventures says its mandate includes generating top returns, and a strategic fit that loses money is hard to defend inside the parent.

How common is it in practice? In Canada, a report by BDC Capital and Deloitte Ventures covering 2019 to 2023 found that only 6% of Canadian corporations with more than $1 billion in revenue made direct venture investments, against about 40% of comparable US companies. Our Canadian venture capital guide covers that report. For a US or global founder the point is simpler: a corporate investor is a normal participant in venture rounds, and each program has its own mix of strategic goals and financial returns.

What founders can gain

Programs describe the benefits on their own pages, and the claims are consistent enough to list.

  • Customer access. Intel Capital says that in 2025 it made nearly 1,000 customer introductions and held more than 25 events, connecting portfolio companies with more than 350 unique customers. Salesforce Ventures describes introductions to Fortune 500 decision makers.
  • Technical and operating help. Intel Capital says it has placed 250 embedded experts and consultants inside portfolio companies. GV says its operating partners help with executive recruiting and communications.
  • Patient capital. Salesforce Ventures calls its model evergreen and says it invests at any stage, which can matter in a later round when funds with fixed life are cautious.
  • Credibility. A well-known buyer in your cap table can reassure customers, though that reassurance is real only if the parent actually buys.
  • Scale of the portfolio. Intel Capital says it has invested more than $20 billion since 1991, and Salesforce Ventures reports over $7 billion across 700-plus companies. Large portfolios give them examples to learn from.

All figures here are the arms’ own marketing numbers. They are useful as a description of what is offered, not as proof of results for any startup.

What founders can lose

The same relationship has a cost, and the lawyers who advise on these deals describe the same list.

Varnum LLP, in an article in the National Law Review dated August 25, 2026, names the terms that can shrink a startup’s room to move:

  • Rights of first refusal, first offer or first negotiation over a sale, key intellectual property or future financing. A buyer may not want to spend time on a deal that the parent can match, which weakens your leverage when you sell.
  • Exclusive or near-exclusive licenses, most-favored-nation pricing and supply or distribution deals with the parent.
  • Board seats and observer rights held by someone with a second employer.
  • Vetoes over sales, new debt and changes to the charter.
  • Information rights covering roadmaps, financials and customer data, a competitive risk when the parent sells in your market.
  • Related-party dealings with the parent.
  • Market perception: a visible tie to one parent can frighten away its competitors, which shrinks your pool of customers, partners and acquirers.

Hogan Lovells made a similar point in a 2017 article on five terms corporate venture investors ask for. It calls the right of first refusal usually the most contested, and notes that a CVC’s board designee may face more complex fiduciary questions, because the parent and the fund’s investors do not always want the same thing.

Strategic conflict

If the parent has a product that overlaps yours, or might in two years, an investor’s interest in your roadmap is not purely friendly. The mitigation is process, not trust: a short list of who inside the investor may see what, written down.

Information rights

Standard venture documents give larger investors access to financials and plans. The 2020 NVCA model term sheet includes a right to financial statements, a budget and, in a bracketed option, a capitalization table. It also limits the facility-access and information rights to a Major Investor “who is not a competitor”. Corporate investors often are competitors or near-competitors by that test, so the definition of the word matters. Ask who counts as a competitor and whether the corporate investor can be kept out of reports on sensitive material.

Signaling

When one large company backs you, other large companies in the same industry may assume you are tied to it. The effect is hard to measure and differs by sector, but the Varnum article lists it among the real costs. A founder can reduce it by taking money from more than one strategic investor, or by getting the CVC to agree in writing that it has no exclusivity.

Terms to check before you sign

The NVCA model term sheet uses “right of first refusal” for something else. In that document it covers shares that employees holding 1% or more want to sell, with the company first and investors second. A corporate investor’s request to match a sale of the whole company is a different clause. It does not appear in the model, so expect it as an add-on in negotiation. The line-by-line term sheet clauses guide shows where each standard term sits.

Questions worth putting to the investor, and to your lawyer:

  1. Is the right a first refusal, first offer or first negotiation, how long does it last, and what ends it?
  2. How are competitors defined, and are the investor and its parent excluded from that definition?
  3. Who sees the information rights, and can you restrict access to a named group that is walled off from the parent’s product teams?
  4. Does the director or observer sign confidentiality terms that reach the parent?
  5. Are any commercial agreements (license, supply, pricing) separate from the investment and priced at market terms?
  6. What happens to the rights if the parent sells the business unit, or the CVC program closes?

The last point deserves a moment. Corporate programs can be restructured or closed when the parent’s strategy changes. A written transfer or termination mechanism keeps your cap table from depending on a team that no longer exists.

How to vet a corporate investor

Treat the CVC like a business partner you are about to hire, and do the checking before the term sheet arrives.

  • Find the sponsor. A CVC arm can write the check, but value to your startup usually comes from a business unit that wants your product. Ask which executive in the parent will own the relationship and whether that person has agreed to a pilot or a purchase.
  • Talk to founders in the portfolio, including one whose product overlaps with the parent’s. Ask how the CVC treated their information and what happened when the parent’s priorities shifted.
  • Read the program’s own pages for its stated goals. Varnum recommends need-to-know protocols, recusal procedures and confidentiality rules for any director tied to the corporate parent, so ask whether the CVC already works that way.
  • Ask how decisions get made. A bureaucratic approval chain can slow a follow-on round at exactly the wrong time.
  • Plan for the later years. Varnum also advises revisiting restrictions as the business grows, so write in a review point or an expiry date for any exclusivity.

Our due diligence and data room guide covers what the investor will look at in return.

A hypothetical example

Here is an invented case, for illustration only. A startup selling inventory software raises a $6 million round led by a venture fund, with a corporate arm of a large retailer taking $1.5 million. The retailer’s term sheet asks for a board observer, quarterly access to sales data by customer, and a right of first negotiation on any sale of the company for three years.

The founders take the money but agree on edits. Sales data goes only to two named people in the retailer’s venture team, who sign a confidentiality agreement that bars sharing with the merchandising group. The negotiation right shrinks to 15 business days after a written offer, and drops away if the retailer launches a competing product. The retailer’s rivals, who are prospects, are told about the safeguards in plain terms. None of it is guaranteed to work. It does show the shape of the usual trade: the corporation keeps a view and a first look, and the founders keep the right to sell elsewhere.

Questions founders ask

Is corporate money better than a venture fund’s? It depends on what you need. A strategic investor can open doors that a fund cannot, and it can also narrow who will buy you. The tradeoff is specific to the parent and the terms.

Do CVCs lead rounds? Some do. Intel Capital says it leads about 75% of its deals on average. Many other corporate arms join rounds led by a financial fund, which lets the lead set the price and standard terms.

Does a CVC investment lead to an acquisition? Not usually. The Salesforce Ventures figure above (under 5% of its portfolio acquired by Salesforce) is one data point from one program, and it shows that most strategic investments stay investments.

Can I take money from two competing corporates? Often yes if neither holds exclusivity and the information rights are fenced. Each investor will read the other’s rights, so negotiate them in parallel.

What if the CVC arm shuts down? The investor normally still holds its shares and the rights attached to them. Ask who will exercise the consent rights afterwards and what happens to them if the stake is sold on.

For related reading, see angels and VCs compared, exits and earn-outs and who not to take money from. The venture capital hub lists the rest.

Sources and limits

  • Intel Capital, intelcapital.com, accessed November 2026: founded 1991, over $20 billion invested, about 75% of deals led, 2025 customer-introduction figures, embedded experts.
  • Salesforce Ventures, salesforceventures.com/about, figures as of July 31, 2026: over $7 billion invested, 700-plus portfolio companies, Salesforce as sole source of capital, fewer than 5% acquired.
  • GV, gv.com/about, accessed November 2026: Alphabet as sole limited partner, launch in 2009, statement that it can invest in competitors of Google.
  • M12, m12.vc, accessed November 2026: strategy aligned to Microsoft, seed to Series B focus.
  • Varnum LLP, “Protect Startup Flexibility: Corporate Venture Capital Deal Terms,” National Law Review, August 25, 2026.
  • Hogan Lovells, “Corporate Venture Capital: Variations on a Theme (5 Key Terms),” November 30, 2017.
  • NVCA, model term sheet for a Series A preferred stock financing, 2020 version, nvca.org.
  • BDC Capital and Deloitte Ventures, State of corporate venture capital in Canada (2019 to 2023 data), bdc.ca.

Program figures come from each arm’s own website and carry its marketing aim. We found no independent source we could open for the share of CVC deals that lead to acquisitions or for the performance of corporate-backed startups against others, so this page does not state one. The hypothetical example uses invented figures. Terms differ by jurisdiction and by deal. This page is general information and not investment, legal or tax advice.